CTICのニュース
CTI BioPharma Corp. (NASDAQ: CTIC): Moving Toward A Higher Share Price 2022/06/24 13:00:00 Stocks Register
CTI BioPharma Corp. (NASDAQ:CTIC) shares, rose in value on Thursday, 06/23/22, with the stock price down by -0.17% to the previous day’s close as strong demand from buyers drove the stock to $5.96. Actively observing the price movement in the last trading, the stock closed the session at $5.97, falling within a range of $5.63 … CTI BioPharma Corp. (NASDAQ: CTIC): Moving Toward A Higher Share Price Read More »
CTI BioPharma Corp. (NASDAQ: CTIC) Could Soon Experience A Sharp Increase In Its Share Price. 2022/06/21 19:00:00 Marketing Sentinel
In today’s recent session, 1.47 million shares of the CTI BioPharma Corp. (NASDAQ:CTIC) have been traded, and its beta is 0.86. Most recently the company’s share price was $6.18, and it changed around $0.05 or 0.73% from the last close, which brings the market valuation of the company to $632.00M. CTIC at last check was … CTI BioPharma Corp. (NASDAQ: CTIC) Could Soon Experience A Sharp Increase In Its Share Price. Read More »
Companies - CTI BioPharma Corp. Given Average Recommendation of “Buy” by Analysts 2022/06/20 09:43:10 Business Mag
CTI BioPharma Corp. has been given an average rating of “Buy” by the six ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the…
CTI BioPharma slips after disclosing data for myelofibrosis therapy 2022/06/10 12:31:56 Seeking Alpha
CTI BioPharma (CTIC), a commercial-stage biotech focused on blood-related cancers, dropped ~9% in the pre-market Friday after the company disclosed data for its FDA-approved…
CTI BioPharma rallies 19% to post a 52-week high 2022/06/08 15:31:59 Seeking Alpha
Commercial stage biotech CTI Biopharma (CTIC) has added ~19% in morning hours Wednesday to post the biggest intraday gain since March and reach a 52-week high on above average volume…
CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Wednesday, June 16 2021/06/09 00:00:00 BioSpace
CTI BioPharma Corp. announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at 2:30 p.m. ET.
CTI BioPharma (CTIC) Q1 2021 Earnings Call Transcript 2021/06/02 04:00:26 The Motley Fool
CTIC earnings call for the period ending March 31, 2021.
CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q1 2021 Results - Earnings Call Transcript 2021/06/02 01:16:04 Seeking Alpha
CTI Biopharma net loss widens on R&D expenses, preparations for drug launch 2021/06/01 20:47:55 Seeking Alpha
Must-See Earnings Estimates NASDAQ:RMBL NASDAQ:CALA NASDAQ:CTIC NASDAQ:URGN and #Covid-19 (#Coronavirus) impact 2021/03/21 02:58:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
CTI BioPharma (NASDAQ:CTIC) Announces Quarterly Earnings Results 2021/03/19 11:28:41 Transcript Daily
CTI BioPharma (NASDAQ:CTIC) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.20) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.16) by ($0.04), MarketWatch Earnings reports. Shares of NASDAQ CTIC opened at $3.27 on Friday. The firm’s 50-day moving average price is $3.32 and its 200-day moving […]
CTI BioPharma (NASDAQ:CTIC) Releases Earnings Results, Misses Expectations By $0.04 EPS 2021/03/19 04:29:29 Daily Political
CTI BioPharma (NASDAQ:CTIC) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04), MarketWatch Earnings reports. Shares of NASDAQ CTIC opened at $3.27 on Friday. The stock has a market cap of $246.79 million, a P/E ratio of -4.81 and a […]
CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results 2021/03/17 20:05:00 PR Newswire
SEATTLE, March 17, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended December 31, 2020. "This past quarter, CTI has executed on the critical clinical, regulatory and commercial activities that will allow…
CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4 2021/02/25 12:00:00 PR Newswire
SEATTLE, Feb. 25, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen 41st Annual Health Care Conference at 12:10 p.m. EST. The conference will be held in a virtual meeting format. Presentation details:…